Clinical Trials Browser

Interventional × BAY 1895344 × Lymphoid × Clear all

NCT05071209 2026-01-23

Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors

Phase 1/2 Active not recruiting

31 enrolled 14 charts

LymphoidSarcoma

Lymphoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

NCT03188965 2023-10-11

First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Phase 1 Completed

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell